1. Halliwell, B. The role of oxygen radicals in human disease
with particular reference to the vascular system.
Haemostasis 1993;23:118-126.
2. Armstrong, D. eds. Free radicals in diagnostic medicine. New
York: Plenum Press, 1994.
3. Halliwell, B. Free radicals, antioxidants and human disease:
Curiosity, cause or consequence. Lancet 1994;344:721-724.
4. Betteridge, D. J. What is oxidative stress? Metabolism
2000;2(Suppl 1):1-9.
5. Lefer, D. & Granger, D. N. Oxidative stress and cardiac disease.
Am J Med 2000;109:315-323.
6. Mccard, J. M. The evolution of free radicals and oxidative
stress. Am J Med 2000;108:652-659.
7. Alfrey, A. C. Role of iron and oxygen radicals in the progression
of chronic renal failure. Am J Kidney Dis
1994;23:183-187.
8. Ichikawa, M. Renal antioxidant enzymes: Their regulation
and function. Kidney Int 1994;45:1-9.
9. Rajbala, A., Sane, A. S., Zope, J., Mishra, V. V.& Trivedi, H. L.
Oxidative stress status in children with nephrotic syndrome.
Panminerva Med 1997;39:165-168.
10. Turi, S., Nemeth, I., Torkos, A., Saghy L., Varga I.,
Matkovisc B. & Nagy J. Oxidative stress and antioxidant
defence mechanism in glomerular diseases. Free Radic Biol
Med 1997;22:161-168.
11. Das, U. N., Mohan, I. K.& Raju, T. R. Effects of corticosteroids
and eicosapentaenoic acid/docosahexaenonic acid
on pro-oxidant and antioxidant status and metabolism
of essentially fatty acids in patients with glomerular disorders.
Prostaglandins Leukot Essent Fatty Acids
1997;65:197-203.
12. Fydryk, J., Jacobson, E.& Kurzawska, O., Malecka G., Gonet
B., Urasinski T., Brodkiewicz A. & Bukowska H. Antioxidant
status of children with steroid sensitive nephrotic syndrome.
Pediatr Nephrol 1998;12:751-754.
13. Baynes, J. W.& Thrope, S. R. Role of oxidative stress in diabetic
complications. Diabetes 1999;48:1-9.
14. Mocan, H., Aksoy, A., Uydu, H. A.& Mocan, M. C.
Oxidative damage of erythrocyte membrane in nephrotic
syndrome. Pediatr Nephrol 1999;13:326-332.
15. Bulucu, F., Vural, A., Ayd›n, A.& Sayal, A. Oxidative stress
status in adults with nephrotic syndrome. Clin Nephrol
2000;53:169-173.
16. Kinra, S., Rath, B. & Kabi, B. C. Indirect quantification
of lipid peroxidation in steroid responsive nephrotic syndrome.
Arch Dis Child 2000;82:76-78.
17. Kuroda, M., Asaka, S., Tofuku, Y.& Takeda, R. Serum antioxidant
activity in uremic patients. Nephron 1985;41:293-298.
18. Adler, S. Baker, P. J., Johnson, R. J., Ochi, R. F., Pritzl, P.&
Couser, W. G. Complement membrane attack complex stimulates
production of reactive oxygen metabolites by cultured
rat mesangial cells. J Clin Invest 1986;39:762-767.
19. Ayd›n, A., Orhan, H., Sayal, A., Özata, M., Sahin, G.& Is›mer,
A. Oxidative stress and nitric oxide related parameters in
type II diabetes mellitus: effects of glycemic control. Clin
Biochem 2001;34:65-70.
20. Richard, M. J., Arnaud, J., Jurkowitz, C., Hachache T., Meftahi
H., Laporte F., Foret M., Favier A. & Cordonnier D. Trace elements
and lipid peroxidation abnormalities in patients with
chronic renal failure. Nephron 1991;57:10-15.
21. Podracka, L., Sasinka, M., Racz, O., Sipulova, A. & Boor, A.
Antioxidant enzyme activity in erythrocytes in children with
kidney diseases. Cas Lek Cesk 1996;15:313-316.
22. Zima, T., Tesar, V., Rychlik, I., Nemecek K., Poledne R.,
Teminova J., Stipek S. & Merta M. The influence of
pefloxacine on experimental adriamycin-induced nephrotic
syndrome in rats. Ren Fail 1996;18:195-199.
23. Zima, T., Tesar, V., Rychlik, I. Nemecek K., Poledne R.,
Teminova J., Stipek S.& Merta M. The influence of
cyclosporine on lipid peroxidation and superoxide dismutase
in adriamycin nephropathy in rats. Nephron
1997;75:464-468.
24. Horie, K., Miyata, T.& Maeda, K., Miyata S., Sugiyama S.,
Sakai H., Van Ypersole De Striohu C., Monnier V.M., Witztum
J.L. & Kurokawa K. Immunohistochemical colocalization of
glycoxidation products and lipid peroxidation products in
diabetic renal glomerular lesions: Implication for glycoxidative
stress in the pathogenesis of diabetic nephropathy. J Clin
Invest 1994;15:2995-3004.
25. Zima, T., Tesar, V., Crkovska, J., Stejskalova A., Platenik J.,
Teminova J., Nemecek K., Janebova M., Stipek S. ICRF-187
(Dexrazoxan) protects from adriamycin-induced nephrotic
syndrome in rats. Nephrol Dial Transplant 1998;13:1975-
1979.
26. Van Den Branden, C., Ceyssens, B., De Craemer, D.,
Pauwels M., Vanden Houte K., De Bleser P., Hellemans K.,
Geerts A. & Verbeelen D. Renal antioxidant enzymes and
fibrosis-related markers in the rat adriamycin model.
Nephron 2000;86:167-175.
27. Warwick, G. L., Waller, H. & Ferns, G. A. Antioxidant
vitamin concentrations and LDL oxidation in nephrotic
syndrome. Ann Clin Biochem 2000;37:488-491.
28. Zachwieja, J., Bobkowski, W., Niklas, A., Strzykala, K.&
Maciejewski, J. Total antioxidant status in children with
nephrotic syndrome. Pol Merkuriusz Lek 2000;8:216-217.
29. Dogra, G., Ward, N.& Croft, K. D., Mori T. A., Barret P.H.,
Herrmann S. E., Irish A. B. Watts G. Oxidant stress in
nephrotic syndrome: Comparison of F(2)-isoprostanes and
plasma antioxidant potential. Nephrol Dial Transplant 2001;16:1626-1630.
30. Skrzep-Poloczek, B., Tomasik, A., Tarnawski, R., Hyla-Klekot
L., Dyduch A., Wojciechowska C., Wesolowski W.,
Kopieczna-Grzebieniak E.& Zalejska-Fiolka J. Nephrotic origin
hyperlipidemia, relative reduction of vitamin E level and
subsequent oxidative stress may promote atherosclerosis.
Nephron 2001;89:68-72,.
31. Bertani, T., Poggi, A., Pozzoni, R., F., Deliani F., Sacchi G.,
Thoua Y., Mecca G., Remuzzi G.& Donati M.B. Adriamycininduced
nephrotic syndrome in rats: Sequence of pathologic
events. Lab Invest 1982;46:16-23.
32. Hall, R. L., Wilke, W. L.& Fettman, M. J. The progression of
adriamycin-induced nephrotic syndrome in rats and the
effect of captopril. Toxicol Appl Pharmacol 1986;82:164-174.
33. Wang, Z., Wang, Z. G. & Liu, Z. Changes of glomerular fixed
anionic charge sites in adriamycin nephrosis in rats. Chin
Med J 1991;104:128-131.
34. Pedraza-Chaverri, J., Arevalo, A. E., Hernandez-Pando, R. &
Larriva-Sahd, J. Effect of dietary antioxidants on purumycin
aminonucleoside nephrotic syndrome. Int J Biochem Cell
Biol 1995;27:683-691.
35. Raats, C. J., Bakker, M. H., Van Den Born, J. & Berden, H. M.
Hydroxyl radicals depolymerize glomerular heparan sulfate
in vitro and in experimental nephrotic syndrome. J Biol
Chem 1997;272(42):26734-26741.
36. Ohtake, T., Kimura, M., Nishimura, M. & Hishida, A. Role of
reactive oxygen species and antioxidant enzymes in
murine daunomycin induced nephropathy. J Lab Clin Med
1997;129:81-88.
37. Korsetz, Z., Pomeranz, A., Golan, E.& Berheim, J. Pefloxacin
in adriamycin induce nephrotic syndrome in the rat. Nephrol
Dia. Transplant 1998;13:1975-1979.
38. Thabrew, M. I., Samarawickrema, N., Chandrasena, L. G. &
Jayasekera, S. Effect of oral supplementation with vitamin E
on the oxido-reductive status of red blood cells in
normal mice and mice subject to oxidative stress by chronic
administration of adriamycin. Ann Clin Biochem
1999;36:216-220.
39. Thabrew, M. I., Samarawickrema, N., Chandrasena, L. G. &
Jayasekera, S. Protection by garlic against adriamycin
induced alterations in the oxido-reductive status of mouse
red blood cells. Phytother Res 2000;14:215-217.
40. Badary, O. A., Abdel-Naim, A. B., Abdel-Wahab, M. H.&
Hamada, F. M. The influence of thymoquinone on doxorubicin-
induced hyperlipidemic nephropathy in rats.
Toxicology 2000;7:219-226.
41. Rangan, G. K., Wang, Y. & Harris, D. C. Induction of proteinuric
chronic glomerular disease in the rat (Rattus
Norvegicus) by intracardiac injection of doxorubicin
hydrochloride. Contemp Top Lab Anim Sci 2001;40:44-49.
42. Tesar, V., Zima, T., Jirsa, M., Crkovska J., Stipek S., Vernerova
Z.& Serakova M. Influence of losartan and enalapril on urinary
excretion of 8-isoprostane in experimental nephrotic
syndrome. Med Sci Monit 2002;8:23-28.
43. Bertolatus, J. A., Klinzman, D., Bronsema, D. A., Ridnour, L.
& Oberley, L. W. Evaluation of the role of reactive oxygen
species in doxorubicin hydrochloride nephrosis. J Lab Clin
Med 1991;118:435-445.
Thank you for copying data from http://www.arastirmax.com